Rythmodan
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Some pharmacokinetic parameters of disopyramide in a steady-state situation were studied in 8 patients with arrhythmias. Four…
SummaryEight healthy male volunteers took a single oral dose of one of the following: Rythmodan (conventionally formulated…
SummaryThe bioavailability of two slow release preparations of disopyramide has been compared in a randomized cross-over trial of…
A multi-centre double-blind randomized study is reported in which the effect on mortality of oral disopyramide (300 mg loading…
A Phase I Study was carried out on disopyramide phosphate retard (slow-release) tablets in healthy Japanese subjects, employing…
The authors had 75 patients with myocardial infarction under observation. After the 15th day of the disease various disorders of…
1 The haemodynamic and electrocardiographic effects of intravenous disopyramide were studied in fifteen patients with acute…
1 Serum, urine and pharmacologic effect (prolongation of the QT interval) kinetics of the antiarrhythmic disopyramide have been…
Disopyramide (Rythmodan - Roussel) is an anti-arrhythmic drug for oral use which is being promoted as a ‘new cardio-specific for…